Immuneering IMRX Cash Flow Statement (2020-2026)

NASDAQ IMRX
$4.82 -0.22 (-4.37%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Immuneering Quarterly Cash Flow Statement

Periods 25 quarters
Latest Jun 2026

Immuneering reported cash from operations of -$16.50M and free cash flow of -$16.53M for the quarter ended Jun 2026, down 74.7% year over year. This cash flow statement covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-8.53M-10.97M-12.79M-11.50M-12.97M-13.47M-13.85M-12.34M-13.07M-15.55M-14.52M-14.09M-14.73M-18.14M-15.05M-14.43M-14.96M-11.89M-13.97M-17.92M
Share-based Compensation
2.76M3.72M3.83M3.60M1.05M1.27M1.33M1.48M1.64M1.47M1.66M1.64M1.72M1.69M1.52M1.46M1.64M1.64M1.63M
Cash from Operations
-9.03M-9.24M-12.28M-9.45M-10.62M-11.75M-14.42M-10.75M-12.03M-11.78M-15.49M-11.53M-13.47M-14.51M-14.08M-9.45M-11.98M-9.84M-18.43M-16.50M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles
0.03M0.04M0.14M0.14M0.13M0.11M0.19M0.12M0.31M0.40M0.16M0.01M0.08M0.08M0.08M0.09M0.09M0.09M0.40M0.58M
Depreciation & Amortization (CF)Depreciation & Amortization
0.09M0.09M0.09M0.09M0.09M0.08M0.08M0.08M0.08M0.08M
Change in Working Capital
Change in Receivables
-0.02M-0.25M0.03M-0.10M-0.11M-0.06M-0.01M-0.00M
Change in Account Payables
0.36M-0.45M0.25M-0.40M1.10M0.82M-0.43M-0.07M-0.78M0.17M0.12M0.39M-0.68M0.06M-0.69M1.19M-0.97M0.07M-0.09M1.92M
Change in Accured Expenses
0.07M0.55M-2.24M0.51M2.11M0.09M-2.09M0.02M0.85M1.95M-2.76M1.35M0.84M0.38M-1.61M1.15M2.37M0.99M-4.78M1.03M
Other Working Capital Changes
2.57M-0.71M-1.41M-0.62M1.86M0.45M-0.51M-0.17M0.39M-0.08M-0.25M0.79M0.64M-1.48M-1.10M-0.97M0.17M1.41M1.18M3.49M
Investing Activities
Capital Expenditures
0.01M0.01M0.12M0.16M0.39M0.07M0.03M0.09M0.06M0.17M0.04M0.03M0.01M0.01M0.01M0.00M0.01M0.12M0.08M0.03M
Change in Acquisitions & Divestments
20.50M32.33M19.25M20.60M19.00M9.25M5.00M19.05M21.43M5.00M5.50M9.00M22.50M
Cash from Investing Activities
-52.77M-22.81M12.40M22.15M-0.88M8.15M18.97M9.16M-23.97M3.13M21.39M4.97M-5.42M5.49M-0.01M-0.00M-0.01M-88.72M-63.07M10.48M
Financing Activities
Other financing activities
0.19M0.03M0.04M0.04M0.24M0.18M0.02M0.01M0.73M0.13M24.87M-24.58M0.17M
Change in Capital Stock
Net Shares Issued and Repurchased
1.45M0.94M1.23M
Net Equity Issued and Repurchased
95.53M4.20M13.68M1.30M
Misc.
Cash from Financing Activities
118.49M0.01M0.19M0.03M-0.02M-0.18M0.24M28.17M0.02M0.01M0.98M4.36M-0.04M13.81M-0.06M213.19M-0.36M0.18M0.02M
Change in Cash
56.68M-32.04M0.32M12.73M-11.52M-3.78M4.79M26.59M-35.98M-8.63M6.88M-6.56M-14.52M-9.06M-0.28M-9.51M201.21M-98.92M-81.32M-6.00M
Free Cash Flow
-9.05M-9.25M-12.40M-9.61M-11.02M-11.82M-14.45M-10.84M-12.08M-11.95M-15.53M-11.56M-13.48M-14.52M-14.09M-9.45M-11.98M-9.96M-18.51M-16.53M
Net Cash Flow
56.68M-32.04M0.32M12.73M-11.52M-3.78M4.79M26.59M-35.98M-8.63M6.88M-6.56M-14.52M-9.06M-0.28M-9.51M201.21M-98.92M-81.32M-6.00M